跳至主要内容
临床试验/NCT06548581
NCT06548581进行中(未招募)不适用

Radiographic and Patient Reported Outcomes Following Joint Arthrodesis Following the Use of the SpeedPlate™ Rapid Compression Implants: An Ambidirectional Cohort Study

Treace Medical Concepts, Inc.5 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2024年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
92
试验地点
5
主要终点
Evaluate union vs non-union

研究概览

简要总结

Post-market, observational, multicenter, unblinded, ambidirectional cohort study to evaluate outcomes of study participants treated with the SpeedPlate™ product.

Up to 200 participants will be treated in this study at (up to) 15 clinical sites.

Patients 14 years of age or older that have had MTP and/or TMT joint fixation with the SpeedPlate™ Rapid Compression Implants will be eligible to participate based on the inclusion and exclusion criteria defined in this protocol.

详细描述

The objectives of this study are to evaluate:

  1. Healing/union rates following joint fixation using the SpeedPlate™ Rapid Compression Implants
  2. Whether early weight-bearing (WB) following joint fixation using the SpeedPlate™ Rapid Compression Implants affects the healing/union rates
  3. Quality of life, pain scores and patient satisfaction following joint arthrodesis using the SpeedPlate™ Rapid Compression Implants

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients satisfying the following criteria will be considered and eligible for participation:
  • Patients who have had MTP and/or TMT joint fixation using at least one SpeedPlate™ Rapid Compression Implant (Index Procedure);
  • Males and females ages 14 years of age or older at the time of the Index Procedure;
  • Patients who have completed at least their 6-week post-operative visit but have not yet completed their 12-month post-operative visit;
  • Adequate pre-operative AP and lateral weight-bearing radiographs collected within 6 months of the Index Procedure;
  • Patients must be capable of completing self-administered questionnaires;
  • Willing and able to provide written informed consent.

排除标准

  • Patients satisfying the following criteria will not be eligible for participation:
  • Female patients of childbearing potential with positive pregnancy result at time of consent;
  • Unwilling or unable to schedule and return for follow-up visits;
  • Surgery for MTP or TMT joint arthrodesis on operative foot prior to Index Procedure;
  • Joint arthrodesis using other plating constructs in addition to the SpeedPlate™ Implant(s) at MTP or TMT joint at the time of Index Procedure;
  • Surgeries on operative foot involving fusion of the foot or ankle joints prior to, or at the time of, Index Procedure (other than hammertoe or lesser toes/digits);
  • Clinically significant neuropathy at time of Index Procedure;
  • Untreated Moderate - Severe Osteoarthritis of 1st, 2nd, or 3rd TMT or MTP during the Index Procedure;
  • Untreated Moderate - Severe Osteoarthritis of the foot or ankle outside of the 1st, 2nd or 3rd TMT or MTP joints at the time of Index Procedure;
  • BMI >40 kg/m² at time of Index Procedure;
  • Use of structural bone graft during the Index Procedure;
  • Additional concomitant procedure during the Index Procedure that would have altered patient's ability to early weight-bear post-procedure.
  • Patient is actively involved with a workman's compensation case or is currently involved in litigation;
  • Patient is currently or has participated in a clinical study in the last 30 days prior to signing informed consent or is considering participation in another research protocol during this study; exceptions to this include survey clinical studies with no treatment or if participant is greater than 12 months post-procedure in either the Treace ALIGN3D™, Mini3D™ or MTA3D™ study without ongoing protocol defined adverse events;
  • Patient has a condition or finding that, in the opinion of the Investigator, may jeopardize the patient's well-being, the soundness of this clinical study, or could interfere with provision of informed consent, completion of tests, therapy, or follow-up.

结局指标

主要结局

Evaluate union vs non-union

时间窗: 12 Months

Evaluate clinical/radiographic healing (union vs non-unio). Non-union is defined as radiographic lucency and clinical pain at the 1st, 2nd, and/or 3rd TMT or MTP joint at 12 months post Index.

次要结局

  • Evaluate non-surgical clinical complications or health conditions that could affect outcomes related to the implants or procedure.(24 Months)
  • Evaluate the Intermetatarsal Angle(6 Weeks, 3-4 Months, 6 Months, 12 Months, 24 Months)
  • Evaluate time to start weight-bearing in shoes.(Days after surgery - on average up to 6 weeks)
  • Evaluate patient-reported quality of life, post surgery.(6 Months, 12 Months, 24 Months)
  • Evaluate patient-reported satisfaction, post surgery.(12 Months, 24 Months)
  • Evaluate surgical clinical complications or health conditions that could affect outcomes related to the implants or procedure.(24 Months)
  • Evaluate the Tibial Sesamoid(6 Weeks, 3-4 Months, 6 Months, 12 Months, 24 Months)
  • Evaluate time to start weight-bearing in a boot.(Days after surgery - on average up to 2 weeks)
  • Evaluate time to start unrestricted activity.(Days after surgery - on average up to 4 months)
  • Evaluate the Hallux Valgus Angle(6 Weeks, 3-4 Months, 6 Months, 12 Months, 24 Months)
  • Evaluate patient-reported pain, post surgery.(6 Months, 12 Months, 24 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

The SpeedPlate™ Rapid Compression Implant Study (The... | 临床试验